June 18, 2020
Sweden-based, digital healthcare company, KRY (known as Livi outside of the Nordics) has announced that it has merged with healthcare company Helsa, which operates fourteen health centres across five regions in Sweden.
WHAT’S THE IMPACT
From mid-August, the merger will combine the benefits of digitalisation with physical health centres and enable KRY to treat more symptoms, whilst continuing to...
April 30, 2020
Welcome to the USA. Swedish telehealth platform Kry is moving across the Atlantic and launching its services in the U.S., according to CNBC. It will be offering LIVI, its digital doctor consultation service that lets patients request a visit via the app. Patients can access a doctor for physical conditions and behavioral health.
In January the startup scored €140 million ($155 million) Series C...
January 27, 2020
Globally, one in two individuals are estimated to experience a mental health problem in their lifetime, according to the OECD, which can impact their overall health and relationships.
However, with healthcare systems around the world grappling with challenges including an increasing burden of chronic disease and ageing populations, efforts to improve access to services in this area are sometimes...
January 7, 2020
Stockholm, Sweden-based telemedicine platform KRY (known as LIVI outside of the Nordics) has announced a €140 million ($155 million) Series C funding round led by Ontario Teachers’ Pension Plan’s Teachers’ Innovation Platform. Existing investors Index Ventures, Creandum and Accel also participated.
WHAT THEY DO
KRY is Sweden’s first digital medicine platform, being founded in 2014 and launched in...
December 17, 2019
It’s no secret that the healthcare industry’s delay in getting up to speed with the digital revolution is posing additional challenges for clinicians already working under immense pressure.
And they’re not alone, as patients themselves are growing increasingly frustrated. In the past few years, we have seen an upward trend in them voicing their struggles, with some even taking a hands-on...
October 28, 2019
The NHS’ use of outdated technology is continuing to hinder the widespread adoption of video consultations across primary care in the UK, according to findings from a new report published by LIVI, the UK division of Swedish digital healthcare provider KRY.
In a survey of 100 GPs, carried out at the beginning of September, nearly 80% of respondents said “poor IT and tech support”,...
October 7, 2019
Juliet Bauer has been appointed managing director of digital GP provider LIVI in the UK, after joining the startup earlier this year from NHS England as VP of product.
Bauer, who was the first chief digital officer for NHS England, will replace Luke Buhl-Nielsen, who will be taking on a new role as VP for business development & operations for the global LIVI (known as KRY in the Nordic...
September 6, 2019
High street pharmacy chain Boots UK has unveiled this week a partnership with Swedish startup LIVI, known as KRY in the Nordic markets, to provide an in-store digital GP consultation service to its customers and NHS patients.
LIVI will initially be piloting an NHS service in a Boots store in north west Surrey, where it has already partnered with GP federations, followed by a private service in...
October 30, 2018
A Swedish digital health firm is launching its doctor-patient video app in the UK this week after signing two partnerships with NHS GP federations that will see it become available to patients registered with GP practices in North West Surrey and the North West of England - the NICS GP Federation and SSP Health.
The Livi app, known as Kry in the Nordic markets, can be used by patients aged 16 and...
September 11, 2018
The Cadillac of gene tests? 23andMe is considering a $749 premium gene test offering, considerably more expensive than the $99 to $199 products the company has offered thus far, CNBC reports. Some users received email notifications about a premium service at that price, but clicking the link did nothing. According to 23andMe, it’s only testing user interest and has no plans for a roll out.